FOXO1 opposition of CD8<sup>+</sup> T cell effector programming confers early memory properties and phenotypic diversity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28973925.
- Also identified by DOI 10.1073/pnas.1618916114 and PMC identifier 5651728.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The factors and steps controlling postinfection CD8<sup>+</sup> T cell terminal effector versus memory differentiation are incompletely understood. Whereas we found that naive TCF7 (alias "Tcf-1") expression is FOXO1 independent, early postinfection we report bimodal, FOXO1-dependent expression of the memory-essential transcription factor TCF7 in pathogen-specific CD8<sup>+</sup> T cells. We determined the early postinfection TCF7<sup>high</sup> population is marked by low TIM3 expression and bears memory signature hallmarks before the appearance of established memory precursor marker CD127 (IL-7R). These cells exhibit diminished TBET, GZMB, mTOR signaling, and cell cycle progression. Day 5 postinfection, TCF7<sup>high</sup> cells express higher memory-associated BCL2 and EOMES, as well as increased accumulation potential and capacity to differentiate into memory phenotype cells. TCF7 retroviral transduction opposes GZMB expression and the formation of KLRG1<sup>pos</sup> phenotype cells, demonstrating an active role for TCF7 in extinguishing the effector program and forestalling terminal differentiation. Past the peak of the cellular immune response, we report a gradient of FOXO1 and TCF7 expression, which functions to oppose TBET and orchestrate a continuum of effector-to-memory phenotypes.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Forkhead Box Protein O1
- Immunologic Memory